The global pediatric vaccines market size reached US$ 37.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 70.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.26% during 2024-2032. More Info:- https://www.imarcgroup.com/pediatric-vaccines-market

1. Global Pediatric Vaccines
Market Research and
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Pediatric Vaccines
Market: Global Industry Trends, Share, Size, Growth, Opportunity and
Forecast 2024-2032," the global pediatric vaccines market size reached US$
37.0 Billion in 2023.
Pediatric vaccines are generally administered to children and infants that are
recommended by organizations and agencies. They are an integral part of
immunization that help the body become resistant to numerous disease-causing
agents, such as viruses and bacteria. They are widely available in multiple
forms that vary on the basis of their route of administration and children’s age
and health.
They include live, inactivated, conjugate, recombinant, toxoid and subunits that
ensure long-lasting protection against the pathogens. Some of the commonly
administered pediatric vaccines are Hepatitis B, Rotavirus, Pneumococcal
conjugate, Influenza, Measles, Varicella, Tetanus and Meningococcal.
Request for a PDF sample of this report:
https://www.imarcgroup.com/pediatric -vaccines-market/requestsample

4. Report Description
Global Pediatric Vaccines Market Trends:
The global market is primarily driven by the growing prevalence of chronic diseases among the pediatric
population. This can be attributed to the increasing birth rates and the rising awareness among parents. Along
with this, numerous initiatives undertaken by various government and non-government organizations of several
countries to raise awareness regarding the importance of pediatric vaccines and conduct vaccination drives are
creating a positive market outlook. In addition to this, the growing investments by public and private agencies in
extensive research and development (R&D) activities in the field of life sciences and genetic engineering are
impacting the market growth favorably.
Furthermore, continuous technological advancements in the vaccination production processes are significantly
supporting the product demand on the global level. The market is further driven by several improvements in the
supply chain processes. Other factors, including continual developments in the healthcare infrastructure, the
establishment of medical facilities across rural and geographical extended locations, and continuous product
innovations, are also positively influencing the market.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/pediatric-vaccines-market

5. Report
Segmentation
Breakup by Type:
• Multivalent
• Monovalent
Breakup by Technology:
• Conjugate
• Live Attenuated
• Inactivated
• Subunit
• Toxoid
• Others
Breakup by Application:
• Infectious Disease
• Cancer

6. Report
Segmentation
• Allergy
• Others
Breakup by Region:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7. Competitive
Landscape with
Key Players
• Abbott Laboratories
• Bio-Med Private Limited
• Daiichi Sankyo Company Limited
• GSK plc
• Indian Immunologicals Limited (National Dairy
Development Board)
• Merck & Co. Inc.
• Mitsubishi Tanabe Pharma Corporation
(Mitsubishi Chemical Holdings Corporation)
• Panacea Biotec Limited
• Pfizer Inc.
• Sanofi S.A.
• Sinovac Biotech Ltd.

8. Key Questions
Answered in
the Report
What was the size of the global pediatric vaccines market in
2023?
What is the expected growth rate of the global pediatric
vaccines market during 2024-2032?
What are the key factors driving the global pediatric vaccines
market?
What has been the impact of COVID-19 on the global pediatric
vaccines market?
What is the breakup of the global pediatric vaccines market
based on the type?
What is the breakup of the global pediatric vaccines market
based on the technology?
What are the key regions in the global pediatric vaccines
market?
Who are the key players/companies in the global pediatric
vaccines market?

9. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pediatric Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Multivalent
6.1.1 Market Trends
6.1.2 Mark et Forecast
6.2 Monovalent
6.2.1 Mark et Trends
6.2.2 Mark et Forecast
7 Market Breakup by Technology
7.1 Conjugate
7.1.1 Mark et Trends
7.1.2 Mark et Forecast

10. Table of
Contents
7.2 Live Attenuated
7.2.1 Mark et Trends
7.2.2 Mark et Forecast
7.3 Inactivated
7.3.1 Market Trends
7.3.2 Mark et Forecast
7.4 Subunit
7.4.1 Mark et Trends
7.4.2 Mark et Forecast
7.5 T oxoid
7.5.1 Mark et Trends
7.5.2 Mark et Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Mark et Forecast
8 Market Breakup by Application
8.1 Infectious Disease
8.1.1 Mark et Trends
8.1.2 Mark et Forecast
8.2 Cancer
8.2.1 Mark et Trends
8.2.2 Mark et Forecast
8.3 Allergy
8.3.1 Mark et Trends
8.3.2 Mark et Forecast
8.4 Others
8.4.1 Mark et Trends
8.4.2 Mark et Forecast
For more information, visit :
https://www.imarcgroup.com/pediatric -vaccines-market/toc

11. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

12. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com